Report cover image

Global Flu Shots Market Analysis and Forecast 2025-2031

Publisher APO Research, Inc.
Published Oct 20, 2025
Length 196 Pages
SKU # APRC20560862

Description

Summary

According to APO Research, The global Flu Shots market is projected to grow from US$ million in 2025 to US$ million by 2031, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Flu Shots is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Asia-Pacific market for Flu Shots is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The China market for Flu Shots is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Europe market for Flu Shots is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The major global manufacturers of Flu Shots include SANOFI, GSK, VAXTEC, TIANYUAN BIO-PHARMA, SIOBP, SINOVAC, LANZHOU INSTITUTE OF BIOLOGICAL PRODUCT, HUALAN BIO and CHANGSHENG, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Flu Shots, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2020 - 2024, estimates for 2025, and projections of CAGR through 2031.

This report researches the key producers of Flu Shots, also provides the sales of main regions and countries. Of the upcoming market potential for Flu Shots, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Flu Shots sales, revenue, market share and industry ranking of main manufacturers, data from 2020 to 2025. Identification of the major stakeholders in the global Flu Shots market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2020 to 2031. Evaluation and forecast the market size for Flu Shots sales, projected growth trends, production technology, application and end-user industry.

Flu Shots Segment by Company

SANOFI
GSK
VAXTEC
TIANYUAN BIO-PHARMA
SIOBP
SINOVAC
LANZHOU INSTITUTE OF BIOLOGICAL PRODUCT
HUALAN BIO
CHANGSHENG
CCBIO
ALEPH BIOMEDICAL
Flu Shots Segment by Type

Influenza Whole Virus Vaccines
Influenza Virus Subunit Vaccines
Influenza Virus Split Vaccines
Flu Shots Segment by Application

Avian Influenza Virus-A
Avian Influenza Virus-B
Flu Shots Segment by Region

North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Flu Shots market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Flu Shots and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Flu Shots.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Sales (consumption), revenue of Flu Shots in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 4: Detailed analysis of Flu Shots manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Flu Shots sales, revenue, price, gross margin, and recent development, etc.
Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.
Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.
Chapter 10: China type, by application, sales, and revenue for each segment.
Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.
Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.
Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 14: The main concluding insights of the report.

Please Note: Single-User license will be delivered via PDF from the publisher without the rights to print or to edit.

Table of Contents

196 Pages
1 Market Overview
1.1 Product Definition
1.2 Flu Shots Market by Type
1.2.1 Global Flu Shots Market Size by Type, 2020 VS 2024 VS 2031
1.2.2 Influenza Whole Virus Vaccines
1.2.3 Influenza Virus Subunit Vaccines
1.2.4 Influenza Virus Split Vaccines
1.3 Flu Shots Market by Application
1.3.1 Global Flu Shots Market Size by Application, 2020 VS 2024 VS 2031
1.3.2 Avian Influenza Virus-A
1.3.3 Avian Influenza Virus-B
1.4 Assumptions and Limitations
1.5 Study Goals and Objectives
2 Flu Shots Market Dynamics
2.1 Flu Shots Industry Trends
2.2 Flu Shots Industry Drivers
2.3 Flu Shots Industry Opportunities and Challenges
2.4 Flu Shots Industry Restraints
3 Global Market Growth Prospects
3.1 Global Flu Shots Revenue Estimates and Forecasts (2020-2031)
3.2 Global Flu Shots Revenue by Region
3.2.1 Global Flu Shots Revenue by Region: 2020 VS 2024 VS 2031
3.2.2 Global Flu Shots Revenue by Region (2020-2025)
3.2.3 Global Flu Shots Revenue by Region (2026-2031)
3.2.4 Global Flu Shots Revenue Market Share by Region (2020-2031)
3.3 Global Flu Shots Sales Estimates and Forecasts 2020-2031
3.4 Global Flu Shots Sales by Region
3.4.1 Global Flu Shots Sales by Region: 2020 VS 2024 VS 2031
3.4.2 Global Flu Shots Sales by Region (2020-2025)
3.4.3 Global Flu Shots Sales by Region (2026-2031)
3.4.4 Global Flu Shots Sales Market Share by Region (2020-2031)
3.5 US & Canada & Mexico
3.6 Europe
3.7 China
3.8 Asia (Excluding China)
3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
4.1 Global Flu Shots Revenue by Manufacturers
4.1.1 Global Flu Shots Revenue by Manufacturers (2020-2025)
4.1.2 Global Flu Shots Revenue Market Share by Manufacturers (2020-2025)
4.1.3 Global Flu Shots Manufacturers Revenue Share Top 10 and Top 5 in 2024
4.2 Global Flu Shots Sales by Manufacturers
4.2.1 Global Flu Shots Sales by Manufacturers (2020-2025)
4.2.2 Global Flu Shots Sales Market Share by Manufacturers (2020-2025)
4.2.3 Global Flu Shots Manufacturers Sales Share Top 10 and Top 5 in 2024
4.3 Global Flu Shots Sales Price by Manufacturers (2020-2025)
4.4 Global Flu Shots Key Manufacturers Ranking, 2023 VS 2024 VS 2025
4.5 Global Flu Shots Key Manufacturers Manufacturing Sites & Headquarters
4.6 Global Flu Shots Manufacturers, Product Type & Application
4.7 Global Flu Shots Manufacturers' Establishment Date
4.8 Market Competitive Analysis
4.8.1 Global Flu Shots Market CR5 and HHI
4.8.2 2024 Flu Shots Tier 1, Tier 2, and Tier 3
5 Flu Shots Market by Type
5.1 Global Flu Shots Revenue by Type
5.1.1 Global Flu Shots Revenue by Type (2020 VS 2024 VS 2031)
5.1.2 Global Flu Shots Revenue by Type (2020-2031) & (US$ Million)
5.1.3 Global Flu Shots Revenue Market Share by Type (2020-2031)
5.2 Global Flu Shots Sales by Type
5.2.1 Global Flu Shots Sales by Type (2020 VS 2024 VS 2031)
5.2.2 Global Flu Shots Sales by Type (2020-2031) & (K Units)
5.2.3 Global Flu Shots Sales Market Share by Type (2020-2031)
5.3 Global Flu Shots Price by Type
6 Flu Shots Market by Application
6.1 Global Flu Shots Revenue by Application
6.1.1 Global Flu Shots Revenue by Application (2020 VS 2024 VS 2031)
6.1.2 Global Flu Shots Revenue by Application (2020-2031) & (US$ Million)
6.1.3 Global Flu Shots Revenue Market Share by Application (2020-2031)
6.2 Global Flu Shots Sales by Application
6.2.1 Global Flu Shots Sales by Application (2020 VS 2024 VS 2031)
6.2.2 Global Flu Shots Sales by Application (2020-2031) & (K Units)
6.2.3 Global Flu Shots Sales Market Share by Application (2020-2031)
6.3 Global Flu Shots Price by Application
7 Company Profiles
7.1 SANOFI
7.1.1 SANOFI Comapny Information
7.1.2 SANOFI Business Overview
7.1.3 SANOFI Flu Shots Sales, Revenue, Price and Gross Margin (2020-2025)
7.1.4 SANOFI Flu Shots Product Portfolio
7.1.5 SANOFI Recent Developments
7.2 GSK
7.2.1 GSK Comapny Information
7.2.2 GSK Business Overview
7.2.3 GSK Flu Shots Sales, Revenue, Price and Gross Margin (2020-2025)
7.2.4 GSK Flu Shots Product Portfolio
7.2.5 GSK Recent Developments
7.3 VAXTEC
7.3.1 VAXTEC Comapny Information
7.3.2 VAXTEC Business Overview
7.3.3 VAXTEC Flu Shots Sales, Revenue, Price and Gross Margin (2020-2025)
7.3.4 VAXTEC Flu Shots Product Portfolio
7.3.5 VAXTEC Recent Developments
7.4 TIANYUAN BIO-PHARMA
7.4.1 TIANYUAN BIO-PHARMA Comapny Information
7.4.2 TIANYUAN BIO-PHARMA Business Overview
7.4.3 TIANYUAN BIO-PHARMA Flu Shots Sales, Revenue, Price and Gross Margin (2020-2025)
7.4.4 TIANYUAN BIO-PHARMA Flu Shots Product Portfolio
7.4.5 TIANYUAN BIO-PHARMA Recent Developments
7.5 SIOBP
7.5.1 SIOBP Comapny Information
7.5.2 SIOBP Business Overview
7.5.3 SIOBP Flu Shots Sales, Revenue, Price and Gross Margin (2020-2025)
7.5.4 SIOBP Flu Shots Product Portfolio
7.5.5 SIOBP Recent Developments
7.6 SINOVAC
7.6.1 SINOVAC Comapny Information
7.6.2 SINOVAC Business Overview
7.6.3 SINOVAC Flu Shots Sales, Revenue, Price and Gross Margin (2020-2025)
7.6.4 SINOVAC Flu Shots Product Portfolio
7.6.5 SINOVAC Recent Developments
7.7 LANZHOU INSTITUTE OF BIOLOGICAL PRODUCT
7.7.1 LANZHOU INSTITUTE OF BIOLOGICAL PRODUCT Comapny Information
7.7.2 LANZHOU INSTITUTE OF BIOLOGICAL PRODUCT Business Overview
7.7.3 LANZHOU INSTITUTE OF BIOLOGICAL PRODUCT Flu Shots Sales, Revenue, Price and Gross Margin (2020-2025)
7.7.4 LANZHOU INSTITUTE OF BIOLOGICAL PRODUCT Flu Shots Product Portfolio
7.7.5 LANZHOU INSTITUTE OF BIOLOGICAL PRODUCT Recent Developments
7.8 HUALAN BIO
7.8.1 HUALAN BIO Comapny Information
7.8.2 HUALAN BIO Business Overview
7.8.3 HUALAN BIO Flu Shots Sales, Revenue, Price and Gross Margin (2020-2025)
7.8.4 HUALAN BIO Flu Shots Product Portfolio
7.8.5 HUALAN BIO Recent Developments
7.9 CHANGSHENG
7.9.1 CHANGSHENG Comapny Information
7.9.2 CHANGSHENG Business Overview
7.9.3 CHANGSHENG Flu Shots Sales, Revenue, Price and Gross Margin (2020-2025)
7.9.4 CHANGSHENG Flu Shots Product Portfolio
7.9.5 CHANGSHENG Recent Developments
7.10 CCBIO
7.10.1 CCBIO Comapny Information
7.10.2 CCBIO Business Overview
7.10.3 CCBIO Flu Shots Sales, Revenue, Price and Gross Margin (2020-2025)
7.10.4 CCBIO Flu Shots Product Portfolio
7.10.5 CCBIO Recent Developments
7.11 ALEPH BIOMEDICAL
7.11.1 ALEPH BIOMEDICAL Comapny Information
7.11.2 ALEPH BIOMEDICAL Business Overview
7.11.3 ALEPH BIOMEDICAL Flu Shots Sales, Revenue, Price and Gross Margin (2020-2025)
7.11.4 ALEPH BIOMEDICAL Flu Shots Product Portfolio
7.11.5 ALEPH BIOMEDICAL Recent Developments
8 North America
8.1 North America Flu Shots Market Size by Type
8.1.1 North America Flu Shots Revenue by Type (2020-2031)
8.1.2 North America Flu Shots Sales by Type (2020-2031)
8.1.3 North America Flu Shots Price by Type (2020-2031)
8.2 North America Flu Shots Market Size by Application
8.2.1 North America Flu Shots Revenue by Application (2020-2031)
8.2.2 North America Flu Shots Sales by Application (2020-2031)
8.2.3 North America Flu Shots Price by Application (2020-2031)
8.3 North America Flu Shots Market Size by Country
8.3.1 North America Flu Shots Revenue Grow Rate by Country (2020 VS 2024 VS 2031)
8.3.2 North America Flu Shots Sales by Country (2020 VS 2024 VS 2031)
8.3.3 North America Flu Shots Price by Country (2020-2031)
8.3.4 United States
8.3.5 Canada
9 Europe
9.1 Europe Flu Shots Market Size by Type
9.1.1 Europe Flu Shots Revenue by Type (2020-2031)
9.1.2 Europe Flu Shots Sales by Type (2020-2031)
9.1.3 Europe Flu Shots Price by Type (2020-2031)
9.2 Europe Flu Shots Market Size by Application
9.2.1 Europe Flu Shots Revenue by Application (2020-2031)
9.2.2 Europe Flu Shots Sales by Application (2020-2031)
9.2.3 Europe Flu Shots Price by Application (2020-2031)
9.3 Europe Flu Shots Market Size by Country
9.3.1 Europe Flu Shots Revenue Grow Rate by Country (2020 VS 2024 VS 2031)
9.3.2 Europe Flu Shots Sales by Country (2020 VS 2024 VS 2031)
9.3.3 Europe Flu Shots Price by Country (2020-2031)
9.3.4 Germany
9.3.5 France
9.3.6 U.K.
9.3.7 Italy
9.3.8 Netherlands
10 China
10.1 China Flu Shots Market Size by Type
10.1.1 China Flu Shots Revenue by Type (2020-2031)
10.1.2 China Flu Shots Sales by Type (2020-2031)
10.1.3 China Flu Shots Price by Type (2020-2031)
10.2 China Flu Shots Market Size by Application
10.2.1 China Flu Shots Revenue by Application (2020-2031)
10.2.2 China Flu Shots Sales by Application (2020-2031)
10.2.3 China Flu Shots Price by Application (2020-2031)
11 Asia (Excluding China)
11.1 Asia Flu Shots Market Size by Type
11.1.1 Asia Flu Shots Revenue by Type (2020-2031)
11.1.2 Asia Flu Shots Sales by Type (2020-2031)
11.1.3 Asia Flu Shots Price by Type (2020-2031)
11.2 Asia Flu Shots Market Size by Application
11.2.1 Asia Flu Shots Revenue by Application (2020-2031)
11.2.2 Asia Flu Shots Sales by Application (2020-2031)
11.2.3 Asia Flu Shots Price by Application (2020-2031)
11.3 Asia Flu Shots Market Size by Country
11.3.1 Asia Flu Shots Revenue Grow Rate by Country (2020 VS 2024 VS 2031)
11.3.2 Asia Flu Shots Sales by Country (2020 VS 2024 VS 2031)
11.3.3 Asia Flu Shots Price by Country (2020-2031)
11.3.4 Japan
11.3.5 South Korea
11.3.6 India
11.3.7 Australia
11.3.8 Taiwan
11.3.9 Southeast Asia
12 South America, Middle East and Africa
12.1 SAMEA Flu Shots Market Size by Type
12.1.1 SAMEA Flu Shots Revenue by Type (2020-2031)
12.1.2 SAMEA Flu Shots Sales by Type (2020-2031)
12.1.3 SAMEA Flu Shots Price by Type (2020-2031)
12.2 SAMEA Flu Shots Market Size by Application
12.2.1 SAMEA Flu Shots Revenue by Application (2020-2031)
12.2.2 SAMEA Flu Shots Sales by Application (2020-2031)
12.2.3 SAMEA Flu Shots Price by Application (2020-2031)
12.3 SAMEA Flu Shots Market Size by Country
12.3.1 SAMEA Flu Shots Revenue Grow Rate by Country (2020 VS 2024 VS 2031)
12.3.2 SAMEA Flu Shots Sales by Country (2020 VS 2024 VS 2031)
12.3.3 SAMEA Flu Shots Price by Country (2020-2031)
12.3.4 Brazil
12.3.5 Argentina
12.3.6 Chile
12.3.7 Colombia
12.3.8 Peru
12.3.9 Saudi Arabia
12.3.10 Israel
12.3.11 UAE
12.3.12 Turkey
12.3.13 Iran
12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
13.1 Flu Shots Value Chain Analysis
13.1.1 Flu Shots Key Raw Materials
13.1.2 Raw Materials Key Suppliers
13.1.3 Manufacturing Cost Structure
13.1.4 Flu Shots Production Mode & Process
13.2 Flu Shots Sales Channels Analysis
13.2.1 Direct Comparison with Distribution Share
13.2.2 Flu Shots Distributors
13.2.3 Flu Shots Customers
14 Concluding Insights
15 Appendix
15.1 Reasons for Doing This Study
15.2 Research Methodology
15.3 Research Process
15.4 Authors List of This Report
15.5 Data Source
15.5.1 Secondary Sources
15.5.2 Primary Sources
15.6 Disclaimer
How Do Licenses Work?
Request A Sample
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.